Charan Leng

537 citations
5 papers · 199 · 1 hit paper · h-index 3

Impact in

    • MicroRNA in disease regulation
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Phagocytosis and Immune Regulation

Papers in

    • Extracellular vesicles in disease 5
    • RNA Interference and Gene Delivery 1
    • Immune cells in cancer 3
    • Phagocytosis and Immune Regulation 1
    • interferon and immune responses 1

Charan Leng

4 papers receiving 195 citations

Charan Leng's Hit Papers

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity 2022 · 190 citations
1900+1+2Years since publication50100150

Peers

Charan Leng
Comparison fields: 5 of 31
  • Cancer Research 93
  • Immunology 72
  • Molecular Biology 153
  • Biomedical Engineering 44
  • Oncology 24
Replace Eriomina Shahaj with:
Eriomina Shahaj Italy
Sumiya Dalangood China
Zuozhong Xie China
Bo-Lin Xiao China
George Daaboul United States
Kay Y. Chong China
Paul C. Pagano United States
Anupama Singh United States
Salma El-Sahhar United Kingdom
Charan Leng relative to Eriomina Shahaj Italy Eriomina Shahaj's profile →
Citations per field
00.5×1.5×
Eriomina Shahaj · 1×
Citations per year

Countries citing papers authored by Charan Leng

Since Specialization
Citations

This map shows the geographic impact of Charan Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charan Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charan Leng more than expected).

Fields of papers citing papers by Charan Leng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charan Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charan Leng. The network helps show where Charan Leng may publish in the future.

Co-authors

The 25 scholars most cited alongside Charan Leng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charan Leng Line = papers co-authored together Charan Leng links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Hit paper breakdown →
2022190
2 20204
3 20214
4 20201
5 20210

About Charan Leng

Charan Leng is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Infectious Diseases, having authored 5 papers that have together received 199 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (3 papers), Immune cells in cancer (3 papers), CAR-T cell therapy research (1 paper), Phagocytosis and Immune Regulation (1 paper), interferon and immune responses (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Cancer Research (93 citations), Immunology (72 citations), Molecular Biology (153 citations), Biomedical Engineering (44 citations) and Oncology (24 citations). Charan Leng has collaborated with scholars based in United States. Frequent co-authors include Sushrut Kamerkar, Olga Burenkova, Christine McCoy, Chang Ling Sia, Kyriakos D. Economides, Sriram Sathyanarayanan, Su Chul Jang, Kelvin Zhang, William K. Dahlberg and Dalia Burzyn. Their work appears in journals such as Science Advances, Cancer Immunology Research, Cancer Research and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact